Details for New Drug Application (NDA): 214982
✉ Email this page to a colleague
The generic ingredient in DIGOXIN is digoxin. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the digoxin profile page.
Summary for 214982
Tradename: | DIGOXIN |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | digoxin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 214982
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIGOXIN | digoxin | TABLET;ORAL | 214982 | ANDA | A-S Medication Solutions | 50090-6708 | 50090-6708-1 | 100 TABLET in 1 BOTTLE (50090-6708-1) |
DIGOXIN | digoxin | TABLET;ORAL | 214982 | ANDA | Aurobindo Pharma Limited | 59651-436 | 59651-436-01 | 100 TABLET in 1 BOTTLE (59651-436-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.0625MG | ||||
Approval Date: | Feb 8, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.125MG | ||||
Approval Date: | Feb 8, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
Approval Date: | Feb 8, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription